SWOG clinical trial number
SWOG-8604
Evaluation of 6-Thioguanine (6-TG)(NSC-752) in Refractory and Relapsing Myeloma
Closed
Phase
Published
Abbreviated Title
Evaluation of 6-Thioguanine (6-TG)(NSC-752) in Refractory and Relapsing Myeloma
Activated
10/15/1986
Closed
12/01/1987
Publication Information Expand/Collapse
1990
A phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma: A Southwest Oncology Group study.